# ProSeed Venture Capital Fund

> ProSeed Venture Capital Fund is a VC fund backing Health Care. See 9 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tel Aviv, Israel
- Total investments: 9
- Last investment: Jul 2010
- Lead investor: 11%
- Last updated: Aug 2026
- Website: http://www.proseed.co.il

ProSeed Venture Capital Fund is a VC fund in Tel Aviv focused on Health Care and Biotechnology. ProSeed, an established Israeli Venture Capital firm since April 2000, provides funding as well as hands-on managerial assistance and analytical support to capable technology-based enterprises.ProSeed specializes in funding companies that require early stage financial support. ProSeed, together with the Technion Research and DevelopmentFoundation (TRDF), played a central role in initiating and establishing the Technion Incubator, with major venture capital firms including, Vertex, Vitalife and Battery along with the Technion-Israel Institute of Technology.

## Contacts

5 contacts available for ProSeed Venture Capital Fund. Shizune tracks 3 team members at ProSeed Venture Capital Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/proseed-venture-capital-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 22% |
| Biotechnology | 2 | 22% |
| Apps | 1 | 11% |
| SaaS | 1 | 11% |
| Medical | 1 | 11% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 44% |
| Series B | 2 | 22% |
| Seed | 1 | 11% |
| Series C | 1 | 11% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 5 | 56% |
| United States | 1 | 11% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Shai Levy | CEO | 2 | https://shizune.co/investors/profile/shai-levy |
| Adina Makover | Life Science Director | 0 | https://shizune.co/investors/profile/dr-adina-makover |
| Yigal Landau | Director | 0 | https://shizune.co/investors/profile/yigal-landau |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| EarlySense | EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts. | $13M | Series C | Jul 23, 2010 |  |
| Digiflex | DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making-Ideal for narrow webapplications printers-A great motivation to replace the traditional low quality film solution-The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track | $100K | Series B | Feb 28, 2010 |  |
| Digiflex | DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making-Ideal for narrow webapplications printers-A great motivation to replace the traditional low quality film solution-The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track |  | Series A | May 31, 2009 |  |
| Correlsense | Correlsense helps businesses achieve IT reliability by detecting degradations and outages caused by poorly performing applications. The company’s award-winning flagship product, SharePath, tracks every transaction through each hop in the data center, providing unprecedented visibility into the infrastructure. Easy to deploy and maintain,SharePath is used by businesses of all sizes to optimize the end-user experience, to minimize the risks associated with new service roll-outs and data center migration, to issue chargebacks for IT resources consumed, and to improve the capacity planning process. The company offers an Express edition of SharePath to measure the end-user experience of cloud-based and on-premise applications. This free enterprise-class software can be downloaded at http://www.real-user-monitoring.com.Correlsense was founded in 2005 and is privately held. |  | Series B | Apr 30, 2009 |  |
| Correlsense | Correlsense helps businesses achieve IT reliability by detecting degradations and outages caused by poorly performing applications. The company’s award-winning flagship product, SharePath, tracks every transaction through each hop in the data center, providing unprecedented visibility into the infrastructure. Easy to deploy and maintain,SharePath is used by businesses of all sizes to optimize the end-user experience, to minimize the risks associated with new service roll-outs and data center migration, to issue chargebacks for IT resources consumed, and to improve the capacity planning process. The company offers an Express edition of SharePath to measure the end-user experience of cloud-based and on-premise applications. This free enterprise-class software can be downloaded at http://www.real-user-monitoring.com.Correlsense was founded in 2005 and is privately held. |  | Series A | Jun 23, 2008 |  |
| Digiflex | DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making-Ideal for narrow webapplications printers-A great motivation to replace the traditional low quality film solution-The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track | $900K | Series A | Mar 31, 2008 |  |
| Vayar Vision | Vayar Vision turns images to knowledge: it's a Google for pictures and images, and a missing link between pixels and text.Transform your images into searchable ones. The visual tags are compatible with environments such as Flickr and Picasa. Vayar exposes hidden, beyond words, connections and associations between images. Vayar visualsearch results can be integrated with various decision support systems, and respond to the user with information, which is attached to the found images. When pixels communicate with words- the possibilities are endless. And you are invited to join the adventure. |  | Series A | Jan 31, 2008 |  |
| APProtect | APProtect Ltd. provides anti-piracy protection solutions for consumer and business software developers and publishers. It offers Trusted Server Protection products to protect CAD tools and scientific applications in companies, universities, and other organizations; Online Software Protector family of products for protecting consumer software; andsplitting machine software, which operates on a binary and splits it into two parts. The company also provides splitting, site installation, and server hosting services. APProtect Ltd. was founded in 2004 and is based in Haifa, Israel. | $750K | Series A | Jul 27, 2006 |  |
| GeneGrafts | GeneGrafts Ltd. is a biotechnology company developing proprietary technology for modulating excitable tissues, such as of brain or heart, by cell therapy. This new paradigm can be used for treatment of various diseases including Parkinson's disease and other neurological disorders or cardiac arrhythmias.They have developed a noveltechnology platform based on transplantation of cell grafts, isolated from the patient's own body, which defines the ion channels. These grafted cells integrate functionally and structurally with the target organ, and their electrical properties are derived from the expressed ion channels. The electrical properties of target organ are modulated in a predetermined way. This technology is designed for treatment of neurological disorders and cardiac arrhythmias. | $800K | Seed | Dec 17, 2003 |  |

9 of 9 investments shown.

## Co-investors
- [Vertex Ventures](https://shizune.co/investors/profile/vertex-ventures) — VC Fund, 8 deals together
- [Vertex Ventures Israel](https://shizune.co/investors/profile/vertex-ventures-israel) — VC Fund, 6 deals together
- [Battery Ventures](https://shizune.co/investors/profile/battery-ventures) — VC Fund, 4 deals together
- [Technion Seed](https://shizune.co/investors/profile/technion-seed) — VC Fund, 4 deals together
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund, 2 deals together
- [eXeed Technology](https://shizune.co/investors/profile/exeed-technology) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Media (entertainment) VC Funds in Israel](https://shizune.co/investors/media-entertainment-vc-funds-israel)
- [Media (entertainment) VC Funds in Israel](https://shizune.co/investors/media-entertainment-vc-funds-israel)

## FAQ

### What does ProSeed Venture Capital Fund invest in?

ProSeed Venture Capital Fund invests primarily in Health Care, Biotechnology and Apps startups, most often at Series A and Series B stage. Most of the 9 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact ProSeed Venture Capital Fund?

Public channels for ProSeed Venture Capital Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at ProSeed Venture Capital Fund?

The team at ProSeed Venture Capital Fund includes Shai Levy (CEO), Adina Makover (Life Science Director) and Yigal Landau (Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co